BRCA1 and esophageal squamous cell carcinoma: Several studies revealed that tumors with high burden of BRCA1/2 signature were more sensitive to platinum therapy in pancreatic and breast cancer1,2, which raises a possibility that a similar mutational pattern in ESCC may facilitate treatment for inoperable patients.